← Insider buys
KPTI

Karyopharm Therapeutics Inc. · Healthcare

CEO Michael Kauffman sold $106K of Karyopharm Therapeutics Inc.

Sold$105,600
$11.00Price
9,600Shares
−1%Stake

What KPTI did after the filing

Prices for KPTI after this filing aren't in yet.

Traded Mon, Nov 26. Filed Tue, Nov 27, 11:17 AM ET, during the session. Not investment advice.